| Abbreviation | Meaning |
| AZGP1 | zinc-alpha-2-glycoprotein |
| CAS | clinical activity score |
| Da | Dalton |
| DED | dry eye disease |
| DEPs | differentially expressed proteins |
| GAGs | glycosaminoglycans |
| GD | Graves’ disease |
| GO | Graves’ orbitopathy |
| ICAM-1 | intercellular adhesion molecule 1 |
| IFNs | interferons |
| IGF-R1 | insulin-like growth factor-1 receptor |
| ILs | interleukins |
| LACRT | lacritin |
| LYZ | lysozyme C |
| MDA | malondialdehyde |
| MS | mass spectrometry |
| NMR | nuclear magnetic resonance |
| PAI-1 | plasminogen activator inhibitor-1 |
| PROL1 | proline-rich protein 1 |
| PRP4 | proline-rich protein 4 |
| RANTES | regulated on activation, normal T-cell expressed and secreted |
| ROS | reactive oxygen species |
| TAO | thyroid associated orbitopathy |
| TED | thyroid eye disease |
| TNFs | tumor necrosis factors |
| TSHR | thyroid-stimulating hormone receptor |
| UGDH | uridine diphosphate (UDP)–glucose-dehydrogenase |
| VEGF | vascular endothelial growth factor) |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |